390 related articles for article (PubMed ID: 8996528)
1. DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines.
Delmastro DA; Li J; Vaisman A; Solle M; Chaney SG
Cancer Chemother Pharmacol; 1997; 39(3):245-53. PubMed ID: 8996528
[TBL] [Abstract][Full Text] [Related]
2. Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation.
Zhan Q; Fan S; Smith ML; Bae I; Yu K; Alamo I; O'Connor PM; Fornace AJ
DNA Cell Biol; 1996 Oct; 15(10):805-15. PubMed ID: 8892753
[TBL] [Abstract][Full Text] [Related]
3. Induction of the growth arrest and DNA damage-inducible gene GADD153 by cisplatin in vitro and in vivo.
Gately DP; Jones JA; Christen R; Barton RM; Los G; Howell SB
Br J Cancer; 1994 Dec; 70(6):1102-6. PubMed ID: 7981060
[TBL] [Abstract][Full Text] [Related]
4. Expression of GADD153 in tumor cells and stromal cells from xenografted tumors in nude mice treated with cisplatin: correlations with cisplatin-DNA adducts.
Johnsson A; Strand C; Los G
Cancer Chemother Pharmacol; 1999; 43(4):348-52. PubMed ID: 10071988
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin and taxol activate different signal pathways regulating cellular injury-induced expression of GADD153.
Gately DP; Sharma A; Christen RD; Howell SB
Br J Cancer; 1996 Jan; 73(1):18-23. PubMed ID: 8554977
[TBL] [Abstract][Full Text] [Related]
6. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
[TBL] [Abstract][Full Text] [Related]
7. Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer.
Kritsch D; Hoffmann F; Steinbach D; Jansen L; Mary Photini S; Gajda M; Mosig AS; Sonnemann J; Peters S; Melnikova M; Thomale J; Dürst M; Runnebaum IB; Häfner N
Int J Cancer; 2017 Oct; 141(8):1600-1614. PubMed ID: 28670762
[TBL] [Abstract][Full Text] [Related]
8. Oxidant-inducible adapt 15 RNA is associated with growth arrest- and DNA damage-inducible gadd153 and gadd45.
Crawford DR; Schools GP; Davies KJ
Arch Biochem Biophys; 1996 May; 329(2):137-44. PubMed ID: 8638945
[TBL] [Abstract][Full Text] [Related]
9. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
10. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines.
Mamenta EL; Poma EE; Kaufmann WK; Delmastro DA; Grady HL; Chaney SG
Cancer Res; 1994 Jul; 54(13):3500-5. PubMed ID: 8012973
[TBL] [Abstract][Full Text] [Related]
11. Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide.
Eymin B; Dubrez L; Allouche M; Solary E
Cancer Res; 1997 Feb; 57(4):686-95. PubMed ID: 9044846
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1, and inhibition of platinum-DNA adduct repair.
Kudo K; Gavin E; Das S; Amable L; Shevde LA; Reed E
Oncogene; 2012 Nov; 31(44):4718-24. PubMed ID: 22266871
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial treatment of ovarian cancer cells with harringtonine and cisplatin results in increased cisplatin-DNA adducts.
Yunmbam MK; Guo Y; Miller MR; Yu JJ
Oncol Rep; 2004 Apr; 11(4):833-8. PubMed ID: 15010881
[TBL] [Abstract][Full Text] [Related]
14. Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells.
O'Neill CF; Hunakova L; Kelland LR
Chem Biol Interact; 1999 Nov; 123(1):11-29. PubMed ID: 10597899
[TBL] [Abstract][Full Text] [Related]
15. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
O'Neill CF; Koberle B; Masters JR; Kelland LR
Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancer.
Los G; Benbatoul K; Gately DP; Barton R; Christen R; Robbins KT; Vicario D; Kirmani S; Orloff LA; Weisman R; Howell SB
Clin Cancer Res; 1999 Jul; 5(7):1610-8. PubMed ID: 10430059
[TBL] [Abstract][Full Text] [Related]
17. Genotoxic stress confers preferential and coordinate messenger RNA stability on the five gadd genes.
Jackman J; Alamo I; Fornace AJ
Cancer Res; 1994 Nov; 54(21):5656-62. PubMed ID: 7923213
[TBL] [Abstract][Full Text] [Related]
18. Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase.
DeHaan RD; Yazlovitskaya EM; Persons DL
Cancer Chemother Pharmacol; 2001 Nov; 48(5):383-8. PubMed ID: 11761456
[TBL] [Abstract][Full Text] [Related]
19. Introduction of gadd153 gene into gastric cancer cells can modulate sensitivity to anticancer agents in association with apoptosis.
Kim R; Ohi Y; Inoue H; Aogi K; Toge T
Anticancer Res; 1999; 19(3A):1779-83. PubMed ID: 10470115
[TBL] [Abstract][Full Text] [Related]
20. Increased GADD gene expression in human colon epithelial cells exposed to deoxycholate.
Scott DW; Mutamba S; Hopkins RG; Loo G
J Cell Physiol; 2005 Jan; 202(1):295-303. PubMed ID: 15316935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]